PIPERACILLIN AND TAZOBACTAM FOR INJECTION
PIPERACILLIN AND TAZOBACTAM FOR INJECTION
Discontinued
DIN Number
02465833
Drug Class
Human
Market Date
Jan 6, 2022
Company
HC
fresenius kabi canada ltd
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02465833
AIG Number0225919008
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
J01CR05 PIPERACILLIN AND BETA-LACTAMASE INHIBITOR
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntravenous
AHFS Classification08:12.16.16
Health Canada Classification
ACTIVE INGREDIENTS (2)
PIPERACILLIN (PIPERACILLIN SODIUM)Active
Strength: 36 G / VIAL
Monograph: PIPERACILLIN (PIPERACILLIN SODIUM)
TAZOBACTAM (TAZOBACTAM SODIUM)Active
Strength: 4.5 G / VIAL
Monograph: TAZOBACTAM (TAZOBACTAM SODIUM)